BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 38360005)

  • 1. Types of RNA therapeutics.
    Goleij P; Babamohamadi M; Rezaee A; Sanaye PM; Tabari MAK; Sadreddini S; Arefnezhad R; Motedayyen H
    Prog Mol Biol Transl Sci; 2024; 203():41-63. PubMed ID: 38360005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumoral RNA-targeted oligonucleotide therapeutics: The third pillar after small molecule inhibitors and antibodies.
    Taniguchi H; Suzuki Y; Imai K; Adachi Y
    Cancer Sci; 2022 Sep; 113(9):2952-2961. PubMed ID: 35701833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The infinite possibilities of RNA therapeutics.
    Mollocana-Lara EC; Ni M; Agathos SN; Gonzales-Zubiate FA
    J Ind Microbiol Biotechnol; 2021 Dec; 48(9-10):. PubMed ID: 34463324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic oligonucleotides.
    Goodchild J
    Methods Mol Biol; 2011; 764():1-15. PubMed ID: 21748630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of antisense oligonucleotide and siRNA-based therapeutics.
    Chi X; Gatti P; Papoian T
    Drug Discov Today; 2017 May; 22(5):823-833. PubMed ID: 28159625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA Therapeutics: the Next Generation of Drugs for Cardiovascular Diseases.
    Bejar N; Tat TT; Kiss DL
    Curr Atheroscler Rep; 2022 May; 24(5):307-321. PubMed ID: 35364795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oligonucleotide therapeutics - an emerging novel class of compounds].
    Wacheck V
    Wien Med Wochenschr; 2006 Sep; 156(17-18):481-7. PubMed ID: 17041803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges.
    Yu AM; Choi YH; Tu MJ
    Pharmacol Rev; 2020 Oct; 72(4):862-898. PubMed ID: 32929000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small non-coding RNA therapeutics for cardiovascular disease.
    Shah AM; Giacca M
    Eur Heart J; 2022 Nov; 43(43):4548-4561. PubMed ID: 36106499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-targeted therapeutics in cardiovascular disease: the time is now.
    Krychtiuk KA; Rader DJ; Granger CB
    Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 9(1):94-99. PubMed ID: 36138490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses.
    Ciccone G; Ibba ML; Coppola G; Catuogno S; Esposito CL
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress on RNA-based therapeutics for genetic diseases.
    Luo T; Huo C; Zhou T; Xie S
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):406-416. PubMed ID: 37643975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the Therapeutic Delivery of Oligonucleotides by Chemical Modification and Nanoparticle Encapsulation.
    Sun Y; Zhao Y; Zhao X; Lee RJ; Teng L; Zhou C
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29027965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic RNA Therapeutics in Cancer.
    Han Y; Shin SH; Lim CG; Heo YH; Choi IY; Kim HH
    J Pharmacol Exp Ther; 2023 Aug; 386(2):212-223. PubMed ID: 37188531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The versatility of oligonucleotides as potential therapeutics.
    Eckstein F
    Expert Opin Biol Ther; 2007 Jul; 7(7):1021-34. PubMed ID: 17665991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis.
    Vickers TA; Koo S; Bennett CF; Crooke ST; Dean NM; Baker BF
    J Biol Chem; 2003 Feb; 278(9):7108-18. PubMed ID: 12500975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-targeted therapeutics in cancer clinical trials: Current status and future directions.
    Barata P; Sood AK; Hong DS
    Cancer Treat Rev; 2016 Nov; 50():35-47. PubMed ID: 27612280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA therapeutics history and future perspectives.
    Duong HQ; Hoang MC; Nguyen TH; Ngo VL; Le VT
    Prog Mol Biol Transl Sci; 2024; 203():99-114. PubMed ID: 38360008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.